The Many Challenges of Narrative Writing Blog The Many Challenges of Narrative Writing Narratives are an essential part of any programs’ story, but often become cumbersome due to…Certara2018年3月13日
Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients On-Demand Webinar Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients In this webinar, Dr. Tom Polasek, a clinical pharmacologist at Certara Strategic Consulting, explained how…Certara2018年3月8日
Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption Blog Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption The ability to estimate systemic exposure from dermal absorption is essential in developing new dermatological…Certara2018年3月2日
Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Publication Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Certara2018年3月1日
A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer Publication A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer Certara2018年2月27日
Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation Publication Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation Certara2018年2月22日
Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions Blog グローバル承認申請のモデリング&シミュレーション (M&S)のための地籍調査 Analogous to how a geologist surveys the “lay of the land” to determine if oil…Certara2018年2月16日
Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor Publication Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor Certara2018年2月15日
Modeling and Simulation of Bone Mineral Density in Japanese Osteoporosis Patients Treated with Zoledronic Acid Using Tartrate-resistant Acid Phosphatase 5b, a Bone Resorption Marker Publication Modeling and Simulation of Bone Mineral Density in Japanese Osteoporosis Patients Treated with Zoledronic Acid Using Tartrate-resistant Acid Phosphatase 5b, a Bone Resorption Marker Certara2018年2月8日
Using PBPK Models to Assess Fetal Drug Exposure Blog Using PBPK Models to Assess Fetal Drug Exposure The tragedy of thalidomide provides a cautionary tale about the potential for birth defects resulting…Certara2018年1月19日